Clinical Trial Update: A Study to Assess the Safety and Tolerability of RC88 for Patients With Advanced Solid Tumours [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 study evaluating the safety and tolerability of RC88 in patients with solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• RC88

Snippet

Sponsor: RemeGen Co., Ltd. | Conditions: Advanced Solid Tumours | Phase 1, Phase 2 | Status: COMPLETED